2026. Effect of Upadacitinib on Biomarkers of Systemic Inflammation in Patients with Moderate-to-Severe Atopic Dermatitis. SKIN The Journal of Cutaneous Medicine. 10, 2 (Mar. 2026), s742. DOI:https://doi.org/10.25251/y5v7d428.